The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.

Allogene Therapeutics, Inc.’s ALLO share price has surged by 5.28%, which has investors questioning if this is right time to ...

Another study found that people who had high levels of vitamin D in their diet had a 25% lower risk of developing colorectal ...

Novel CAR design selectively targets malignant cells for patients with relapsed/refractory CD5-positive hematological diseasesHOUSTON, April 22, ...

Monitoring and analyzing gut microbes may help predict how myeloma patients will respond to CAR T-cell therapy, research ...

As research unfolds, the San Antonio Fire Department has tried to stay ahead of the curve with new and evolving protocols.

Multiple hospitals in the Texas Medical Center suffered power outages Monday afternoon. A Houston Methodist spokesperson ...

Compass Therapeutics (CMPX) announced the first patient has been dosed in an Investigator Sponsored Trial, IST, to evaluate tovecimig for the ...

Chronic lymphocytic leukemia (CLL) cell–derived exosomes demonstrated the ability to alter healthy donor cell function and ...

A KFF Health News analysis underscores that the terminations are sparing no part of the country, politically or ...

TMC could lose millions of dollars in NIH funding raising the threat of job cuts. A legal battle is now expected to end up in ...